SUNNYVALE, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its fiscal third quarter ended September 30, 2008, on Tuesday, October 28, 2008 after the close of the market.
The company will host a management presentation at 2 p.m. Pacific Time on Tuesday, October 28, 2008 to discuss the results. To access the live webcast, please visit Cepheid's website at http://www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.
Interested participants and investors may also listen to the live teleconference call by dialing 866-271-5140 (domestic) or 617-213-8893 (international), and entering participant code 47767586. A replay will be available for seven days beginning at 4 p.m. Pacific Time. Access numbers for this replay are 888-286-8010 (domestic) and 617-801-6888 (international), with participant code 68801630.
Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand
molecular diagnostics company that develops, manufactures, and markets
fully- integrated systems and tests for genetic analysis in the clinical,
industrial and biothreat markets. The Company's systems enable rapid,
sophisticated genetic testing for organisms and genetic-based diseases by
automating otherwise complex manual laboratory procedures. Cepheid's
easy-to-use systems integrate a number of complicated and time-intensive
steps, including sample preparation, DNA amplification and detection, which
enable the analysis of complex biological samples in its proprietary test
cartridges. Through its strong molecular biology capabilities, the Company
is focusing on those applications where rapid molecular testing is
particularly important, such as identifying infectious disease and cancer
in the clinical market; food, agricultural, and environmental testing in
the industrial market; and identifying bio-terrorism agents in the
For Media Inquiries: For Investor Inquiries:
Jared Tipton Jacquie Ross
Cepheid Corporate Communications Cepheid Investor Relations
Tel: (408) 400 8377 Tel: (408) 400 8329
Copyright©2008 PR Newswire.
All rights reserved